These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8786409)
1. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. Christie RH; Chung H; Rebeck GW; Strickland D; Hyman BT J Neuropathol Exp Neurol; 1996 Apr; 55(4):491-8. PubMed ID: 8786409 [TBL] [Abstract][Full Text] [Related]
2. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E. Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663 [TBL] [Abstract][Full Text] [Related]
3. Lipid metabolism and glial lipoproteins in the central nervous system. Hayashi H Biol Pharm Bull; 2011; 34(4):453-61. PubMed ID: 21467629 [TBL] [Abstract][Full Text] [Related]
4. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype. Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888 [TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway. Wilsie LC; Gonzales AM; Orlando RA Lipids Health Dis; 2006 Aug; 5():23. PubMed ID: 16945147 [TBL] [Abstract][Full Text] [Related]
6. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503 [TBL] [Abstract][Full Text] [Related]
7. ApoE: crossroads between Alzheimer's disease and atherosclerosis. Stojakovic T; Scharnagl H; März W Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629 [TBL] [Abstract][Full Text] [Related]
8. Brain lipoprotein metabolism and its relation to neurodegenerative disease. Danik M; Champagne D; Petit-Turcotte C; Beffert U; Poirier J Crit Rev Neurobiol; 1999; 13(4):357-407. PubMed ID: 11028681 [TBL] [Abstract][Full Text] [Related]
9. A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands. Fisher C; Abdul-Aziz D; Blacklow SC Biochemistry; 2004 Feb; 43(4):1037-44. PubMed ID: 14744149 [TBL] [Abstract][Full Text] [Related]
10. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Okuizumi K; Onodera O; Namba Y; Ikeda K; Yamamoto T; Seki K; Ueki A; Nanko S; Tanaka H; Takahashi H; Oyanagi K; Mizusawa H; Kanazawa I; Tsuji S Nat Genet; 1995 Oct; 11(2):207-9. PubMed ID: 7550352 [TBL] [Abstract][Full Text] [Related]
11. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Marais AD Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326 [TBL] [Abstract][Full Text] [Related]
13. Role of chondroitin sulphate in the uptake of beta-VLDL by brain cells. Rapp A; Hüttinger M Eur J Neurosci; 2005 Sep; 22(6):1400-8. PubMed ID: 16190894 [TBL] [Abstract][Full Text] [Related]
14. Uptake and internalization of exogenous apolipoprotein E3 by cultured human central nervous system neurons. Williams KR; Saunders AM; Roses AD; Armati PJ Neurobiol Dis; 1998 Oct; 5(4):271-9. PubMed ID: 9848097 [TBL] [Abstract][Full Text] [Related]
16. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study. Shao Y; Gearing M; Mirra SS J Neuropathol Exp Neurol; 1997 Apr; 56(4):376-81. PubMed ID: 9100668 [TBL] [Abstract][Full Text] [Related]
17. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway. Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460 [TBL] [Abstract][Full Text] [Related]
18. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205 [TBL] [Abstract][Full Text] [Related]
19. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E in the brain and its role in Alzheimer's disease. Poirier J J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]